These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39138154)

  • 1. Insights into the Interaction Landscape of the EVH1 Domain of Mena.
    LaComb L; Ghosh A; Bonanno JB; Nilson DJ; Poppel AJ; Dada L; Cahill SM; Maianti JP; Kitamura S; Cowburn D; Almo SC
    Biochemistry; 2024 Sep; 63(17):2183-2195. PubMed ID: 39138154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based synthetic mimicry of discontinuous protein binding sites: inhibitors of the interaction of Mena EVH1 domain with proline-rich ligands.
    Hunke C; Hirsch T; Eichler J
    Chembiochem; 2006 Aug; 7(8):1258-64. PubMed ID: 16810654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The solution structure of pGolemi, a high affinity Mena EVH1 binding miniature protein, suggests explanations for paralog-specific binding to Ena/VASP homology (EVH) 1 domains.
    Link NM; Hunke C; Mueller JW; Eichler J; Bayer P
    Biol Chem; 2009; 390(5-6):417-26. PubMed ID: 19284291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of polyproline recognition by EVH1 domains.
    Peterson FC; Volkman BF
    Front Biosci (Landmark Ed); 2009 Jan; 14(3):833-46. PubMed ID: 19273103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual epitope recognition by the VASP EVH1 domain modulates polyproline ligand specificity and binding affinity.
    Ball LJ; Kühne R; Hoffmann B; Häfner A; Schmieder P; Volkmer-Engert R; Hof M; Wahl M; Schneider-Mergener J; Walter U; Oschkinat H; Jarchau T
    EMBO J; 2000 Sep; 19(18):4903-14. PubMed ID: 10990454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatic and basic residues within the EVH1 domain of VASP specify its interaction with proline-rich ligands.
    Carl UD; Pollmann M; Orr E; Gertlere FB; Chakraborty T; Wehland J
    Curr Biol; 1999 Jul; 9(13):715-8. PubMed ID: 10498433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal domain of Homer/Vesl is a new class II EVH1 domain.
    Barzik M; Carl UD; Schubert WD; Frank R; Wehland J; Heinz DW
    J Mol Biol; 2001 May; 309(1):155-69. PubMed ID: 11491285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miniature protein ligands for EVH1 domains: interplay between affinity, specificity, and cell motility.
    Holtzman JH; Woronowicz K; Golemi-Kotra D; Schepartz A
    Biochemistry; 2007 Nov; 46(47):13541-53. PubMed ID: 17973491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of N-substituted peptomer ligands for EVH1 domains.
    Zimmermann J; Kühne R; Volkmer-Engert R; Jarchau T; Walter U; Oschkinat H; Ball LJ
    J Biol Chem; 2003 Sep; 278(38):36810-8. PubMed ID: 12857736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel proline-rich motif present in ActA of Listeria monocytogenes and cytoskeletal proteins is the ligand for the EVH1 domain, a protein module present in the Ena/VASP family.
    Niebuhr K; Ebel F; Frank R; Reinhard M; Domann E; Carl UD; Walter U; Gertler FB; Wehland J; Chakraborty T
    EMBO J; 1997 Sep; 16(17):5433-44. PubMed ID: 9312002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution structural analysis of mammalian profilin 2a complex formation with two physiological ligands: the formin homology 1 domain of mDia1 and the proline-rich domain of VASP.
    Kursula P; Kursula I; Massimi M; Song YH; Downer J; Stanley WA; Witke W; Wilmanns M
    J Mol Biol; 2008 Jan; 375(1):270-90. PubMed ID: 18001770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native proline-rich motifs exploit sequence context to target actin-remodeling Ena/VASP protein ENAH.
    Hwang T; Parker SS; Hill SM; Grant RA; Ilunga MW; Sivaraman V; Mouneimne G; Keating AE
    Elife; 2022 Jan; 11():. PubMed ID: 35076015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the enabled/VASP homology 1 domain-peptide complex: a key component in the spatial control of actin assembly.
    Prehoda KE; Lee DJ; Lim WA
    Cell; 1999 May; 97(4):471-80. PubMed ID: 10338211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Noncanonical Binding Site in the EVH1 Domain of Vasodilator-Stimulated Phosphoprotein Regulates Its Interactions with the Proline Rich Region of Zyxin.
    Acevedo LA; Greenwood AI; Nicholson LK
    Biochemistry; 2017 Sep; 56(35):4626-4636. PubMed ID: 28783324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of EVH1, a novel proline-rich ligand-binding module involved in cytoskeletal dynamics and neural function.
    Fedorov AA; Fedorov E; Gertler F; Almo SC
    Nat Struct Biol; 1999 Jul; 6(7):661-5. PubMed ID: 10404224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the Homer 1 family conserved region reveals the interaction between the EVH1 domain and own proline-rich motif.
    Irie K; Nakatsu T; Mitsuoka K; Miyazawa A; Sobue K; Hiroaki Y; Doi T; Fujiyoshi Y; Kato H
    J Mol Biol; 2002 May; 318(4):1117-26. PubMed ID: 12054806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the Homer1 EVH1 domain and skeletal muscle ryanodine receptor.
    Wang T; Zhang L; Shi C; Wei R; Yin C
    Biochem Biophys Res Commun; 2019 Jun; 514(3):720-725. PubMed ID: 31078268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modular toolkit to inhibit proline-rich motif-mediated protein-protein interactions.
    Opitz R; Müller M; Reuter C; Barone M; Soicke A; Roske Y; Piotukh K; Huy P; Beerbaum M; Wiesner B; Beyermann M; Schmieder P; Freund C; Volkmer R; Oschkinat H; Schmalz HG; Kühne R
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5011-6. PubMed ID: 25848013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tes, a specific Mena interacting partner, breaks the rules for EVH1 binding.
    Boëda B; Briggs DC; Higgins T; Garvalov BK; Fadden AJ; McDonald NQ; Way M
    Mol Cell; 2007 Dec; 28(6):1071-82. PubMed ID: 18158903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designed nanomolar small-molecule inhibitors of Ena/VASP EVH1 interaction impair invasion and extravasation of breast cancer cells.
    Barone M; Müller M; Chiha S; Ren J; Albat D; Soicke A; Dohmen S; Klein M; Bruns J; van Dinther M; Opitz R; Lindemann P; Beerbaum M; Motzny K; Roske Y; Schmieder P; Volkmer R; Nazaré M; Heinemann U; Oschkinat H; Ten Dijke P; Schmalz HG; Kühne R
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29684-29690. PubMed ID: 33184177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.